ERBB2 and neoplasm: Unlike TZ or PZ, which only inhibited tumor growth in a xenograft model, TZ‐emtansine caused tumor regression, thus suggesting that a combination of HER2 antibodies with chemotherapeutic agents might be more effective in treating OC than would single agent therapy (Montero et al., 2015).